APstem Therapeutics
PrivateLast Round
VC Round
Sep 7, 2023
Total Funding Raised
$4.3M
Company Overview
APstem Therapeutics is a biotechnology company that develops regenerative cell therapies based on its proprietary Guide-Integrated Adult Stem Cells (giaSCs) platform for the treatment of chronic and incurable diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
APstem Therapeutics Comparables
Compare APstem Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cytora Therapeutics | 77% | |
| Seraxis | 67% | |
| Sana Biotechnology | 65% |
APstem Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 7, 2023 | ||||
| Seed | Sep 1, 2020 | ||||
| Seed | May 1, 2019 | ||||
| Seed | Jan 17, 2018 | ||||
| Accelerator | Jan 1, 2017 |
APstem Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartX | Seed, Accelerator |
| InnoSpring | Seed |
| Beyond Ventures | Seed |
| MFund | Seed |
| Oriza Ventures | Seed |
APstem Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about APstem Therapeutics's valuation, stock price, and market status.
Is APstem Therapeutics a public or private company?
APstem Therapeutics is a private company.
What is the current stock price of APstem Therapeutics?
APstem Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is APstem Therapeutics worth (valuation)?
Valuation information for APstem Therapeutics is not publicly available.
Can I buy APstem Therapeutics stock?
APstem Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was APstem Therapeutics's last funding round?
APstem Therapeutics's most recent funding round was VC Round on September 7, 2023.
Who are the main investors in APstem Therapeutics?
Key investors in APstem Therapeutics include StartX.
Will APstem Therapeutics IPO soon?
No public IPO plans have been announced for APstem Therapeutics.
How can I track APstem Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor APstem Therapeutics's secondary market activity and sign up for updates.